Skip to main content
Clinical Trials/NL-OMON23446
NL-OMON23446
Completed
Not Applicable

Efficacy and safety of adalimumab (humira) in patients with peripheral spondyloarthritis without ankylosing spondylitis or psoriatic artritis.

dr Baeten0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
spondyloartritis, spondylitis ankylosans, artritis psoriatica
Sponsor
dr Baeten
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
dr Baeten

Eligibility Criteria

Inclusion Criteria

  • 1\. Leeftijd 18\-70;
  • 2\. 3 maanden diagnose perifere spondyloartritis en niet voldoen aan classificatie spondylitis ankylosans;

Exclusion Criteria

  • 1\. In 2 maanden voor start behandeling met anti\-TNF of andere studie\-medicatie;
  • 2\. In 4 weken voor start een intra articulaire inject met corticosteroiden;

Outcomes

Primary Outcomes

Not specified

Similar Trials